Uncategorized

  • Imvaria Financing

    IMVARIA Announces Strategic Investments from Leading Healthcare Companies

  • Enveda Phase I Trial

    Enveda Announces US FDA IND Clearance and First Patient Dosed in Phase 1 Trial of ENV-308, a First-in-Class Oral Therapy for Obesity

  • Last Energy Series C

    Nuclear startup Last Energy raises $100M for its steel-encased micro reactor

  • Kobalt Labs Series A

    Kobalt Labs has raised $11 million in Series A funding to enhance its AI-driven platform for automating risk and compliance processes for financial institutions

  • Angle Health Series B

    Angle Health Raises $134 Million to Scale AI-Native Health Benefits Platform for 62 Million SMB Employees Facing Record Increases

  • Model ML Series A

    London and New York-based Model ML raises $75M

  • Synthio Labs Seed

    Synthio Labs Raises $5 Million to Build the Voice AI Operating System for Life Sciences Customer Engagement

  • Character Acquired

    Homewerks Worldwide, LLC Acquires Character’s Project Kits Product Line

  • Lambda Series E

    AI Cloud Company Lambda Raises Over $1.5 Billion

  • EquityZen Acquired

    Morgan Stanley to Acquire Leading Private Shares Platform EquityZen